01 January 1970 1 10K Report

What is the rationale behind co-administration of Ticagrelor 90mg once daily together with Apixaban 5mg BID for patient with stable CAD despite the major drug interaction and risk of bleeding? Is there any clinical evidence for that?

More Hani Guda's questions See All
Similar questions and discussions